SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001882
Filing Date
2023-08-14
Accepted
2023-08-14 16:16:30
Documents
68
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fwbi-20230630x10q.htm   iXBRL 10-Q 1510522
2 EX-31.1 fwbi-20230630xex31d1.htm EX-31.1 12008
3 EX-31.2 fwbi-20230630xex31d2.htm EX-31.2 12021
4 EX-32.1 fwbi-20230630xex32d1.htm EX-32.1 7538
  Complete submission text file 0001410578-23-001882.txt   6781388

Data Files

Seq Description Document Type Size
5 EX-101.SCH fwbi-20230630.xsd EX-101.SCH 57994
6 EX-101.CAL fwbi-20230630_cal.xml EX-101.CAL 39289
7 EX-101.DEF fwbi-20230630_def.xml EX-101.DEF 243215
8 EX-101.LAB fwbi-20230630_lab.xml EX-101.LAB 505562
9 EX-101.PRE fwbi-20230630_pre.xml EX-101.PRE 378651
62 EXTRACTED XBRL INSTANCE DOCUMENT fwbi-20230630x10q_htm.xml XML 1037952
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37853 | Film No.: 231170448
SIC: 2834 Pharmaceutical Preparations